Uchio, E. M., Kulkarni, G. S., Boormans, J. L., Roumiguié, M., Krieger, L. E. M., Singer, E. A., Grivas, P., Seo, H. K., Nishiyama, H., Konety, B. R., Wit, R. D., Kapadia, E., Xing, A., Sigtenhorst-Fijlstra, M. V. D., Kamat, A. M. (2026). Outcomes in participants (pts) with bacillus Calmette-Guérin (BCG)–unresponsive high-risk non–muscle-invasive bladder cancer (NMIBC) who underwent radical cystectomy (RC) after pembrolizumab (pembro): KEYNOTE-057 cohort A post hoc analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.745